Clinical Trial Update: A Study of LY3022855 In Participants With Breast or Prostate Cancer [Phase 1]

View source ↗

Summary

This Phase 1 study of LY3022855 in breast and prostate cancer has completed, with results posted on 2024-10-28.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Prostate Cancer

Drugs mentioned

• LY3022855

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neoplasms, Neoplasm Metastasis | Phase 1 | Status: COMPLETED | Results posted: 2024-10-28